SAILIFE — SAI Life Sciences Balance Sheet
0.000.00%
- IN₹141.73bn
- IN₹149.53bn
- IN₹14.65bn
Annual balance sheet for SAI Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Cash | |||
Short Term Investments | |||
Cash and Short Term Investments | 2,159 | 2,049 | 1,847 |
Net Total Accounts Receivable | |||
Net Total Receivables | 5,577 | 5,744 | 6,300 |
Total Inventory | |||
Prepaid Expenses | |||
Total Other Current Assets | |||
Total Current Assets | 9,454 | 9,640 | 9,451 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 11,527 | 11,765 | 12,730 |
Net Intangible Assets | |||
Long Term Investments | |||
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 21,642 | 21,866 | 22,751 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 7,146 | 7,589 | 7,399 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 12,857 | 12,986 | 13,000 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | 8,786 | 8,881 | 9,751 |
Total Liabilities & Shareholders' Equity | 21,642 | 21,866 | 22,751 |
Total Common Shares Outstanding |